Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy in patients with congenital hypogonadotropic hypogonadism: a multicentre clinical study

BACKGROUND: Pulsatile gonadotropin-releasing hormone (GnRH) therapy may restore function of the hypothalamus-pituitary-gonad axis and induce spermatogenesis in male patients with congenital hypogonadotropic hypogonadism (CHH). The study sought to test the reliability of a newly developed Innopump(®)...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Transl Med
Главные авторы: Hao, Ming, Mao, Jiang-Feng, Guan, Qing-Bo, Tian, Long, Han, Hu, Lei, Hong-En, Zheng, Dong-Mei, Tian, Zhen-Hua, Nie, Min, Wang, Xi, Yu, Bing-Qing, Gao, Yin-Jie, Wu, Xue-Yan
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2021
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8267282/
https://ncbi.nlm.nih.gov/pubmed/34277762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-21-1632
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы